Skip to content


  • Erratum
  • Open Access

Erratum to: Immunotherapy in endometrial cancer - an evolving therapeutic paradigm

Gynecologic Oncology Research and Practice20163:2

  • Received: 19 January 2016
  • Accepted: 20 January 2016
  • Published:

The original article was published in Gynecologic Oncology Research and Practice 2015 2:11

Unfortunately, after publication of the article [1] it was noticed that Table 2 (Table 1 here) was formatted incorrectly during the production process. The corrected table can be seen below and the original article has been updated to reflect this change.
Table 1

Immunotherapeutic approaches and their application to endometrial cancera



Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

University of California, Irvine Medical Center, 101 The City Drive South, Bldg 56, Ste 800, Orange, CA 92868, USA


  1. Longoria TC, Eskander RN. Immunotherapy in endometrial cancer - an evolving therapeutic paradigm. Gynecol Oncol Res Pract. 2015;2:11. doi:10.1186/s40661-015-0020-3.View ArticlePubMedPubMed CentralGoogle Scholar


© Longoria and Eskander. 2016